403
|
Graham RR, Ortmann WA, Langefeld CD, Jawaheer D, Selby SA, Rodine PR, Baechler EC, Rohlf KE, Shark KB, Espe KJ, Green LE, Nair RP, Stuart PE, Elder JT, King RA, Moser KL, Gaffney PM, Bugawan TL, Erlich HA, Rich SS, Gregersen PK, Behrens TW. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002; 71:543-53. [PMID: 12145745 PMCID: PMC379191 DOI: 10.1086/342290] [Citation(s) in RCA: 163] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2002] [Accepted: 06/11/2002] [Indexed: 11/03/2022] Open
Abstract
Human leukocyte antigen (HLA) class I and class II alleles are implicated as genetic risk factors for many autoimmune diseases. However, the role of the HLA loci in human systemic lupus erythematosus (SLE) remains unclear. Using a dense map of polymorphic microsatellites across the HLA region in a large collection of families with SLE, we identified three distinct haplotypes that encompassed the class II region and exhibited transmission distortion. DRB1 and DQB1 typing of founders showed that the three haplotypes contained DRB1*1501/ DQB1*0602, DRB1*0801/ DQB1*0402, and DRB1*0301/DQB1*0201 alleles, respectively. By visualizing ancestral recombinants, we narrowed the disease-associated haplotypes containing DRB1*1501 and DRB1*0801 to an approximately 500-kb region. We conclude that HLA class II haplotypes containing DRB1 and DQB1 alleles are strong risk factors for human SLE.
Collapse
Affiliation(s)
- Robert R. Graham
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Ward A. Ortmann
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Carl D. Langefeld
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Damini Jawaheer
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Scott A. Selby
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Peter R. Rodine
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Emily C. Baechler
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Kristine E. Rohlf
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Katherine B. Shark
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Karl J. Espe
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Linda E. Green
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Rajan P. Nair
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Philip E. Stuart
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - James T. Elder
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Richard A. King
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Kathy L. Moser
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Patrick M. Gaffney
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Teodorica L. Bugawan
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Henry A. Erlich
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Stephen S. Rich
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Peter K. Gregersen
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| | - Timothy W. Behrens
- Department of Medicine, Division of Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis; Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY; Department of Dermatology, University of Michigan Medical School, Ann Arbor; and Human Genetics Department, Roche Molecular Systems, Alameda, CA
| |
Collapse
|